"El VHIO es un destacado centro oncológico integral de excelencia donde los científicos y doctores adoptan un modelo de investigación puramente traslacional, trabajando conjuntamente en equipos multidisciplinares para acelerar y avanzar en el campo de las terapias personalizadas y específicas contra el cáncer."

During the past decade, Vall d´Hebron Institute of Oncology (VHIO), Barcelona conducted 84 clinical trials. In the 10-year time frame, 84 clinical trials started and 4 clinical trials were completed, i.e. on average, 4.8% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 4 clinical trials were completed. i.e. 7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vall d´Hebron Institute of Oncology (VHIO), Barcelona" #1 sponsor was "Hoffmann-La Roche" with 28 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 6 trials sponsored, "Vall d'Hebron Institute of Oncology" with 4 trials sponsored, "Fundación para la Investigación del Hospital Clínico de Valencia" with 3 trials sponsored and "IFOM ETS - The AIRC Institute of Molecular Oncology" with 3 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vall d´Hebron Institute of Oncology (VHIO), Barcelona" #1 collaborator was "Vall d'Hebron Institute of Oncology" with 5 trials as a collaborator, "Amsterdam UMC, location VUmc" with 3 trials as a collaborator, "Hospital Central del IPS" with 3 trials as a collaborator, "INSTITUTO ALEXANDER FLEMING" with 3 trials as a collaborator and "IPATIMUP - Instituto De Patologia E Imunologia Molecular Da Universidade Do Porto" with 3 trials as a collaborator. Other collaborators include 57 different institutions and companies that were collaborators in the rest 59 trials.

According to Clinical.Site data, the most researched conditions in "Vall d´Hebron Institute of Oncology (VHIO), Barcelona" are "Solid Tumors" (8 trials), "Breast Cancer" (7 trials), "Colorectal Cancer" (6 trials), "Ovarian Cancer" (6 trials) and "Fallopian Tube Cancer" (4 trials). Many other conditions were trialed in "Vall d´Hebron Institute of Oncology (VHIO), Barcelona" in a lesser frequency.

Most popular intervention types in "Vall d´Hebron Institute of Oncology (VHIO), Barcelona" are "Drug" (72 trials), "Biological" (7 trials), "Other" (4 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (14 trials), "Placebo" (8 trials), "Ipatasertib" (4 trials), "Tiragolumab" (4 trials) and "Tocilizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Vall d´Hebron Institute of Oncology (VHIO), Barcelona" are 77 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Vall d´Hebron Institute of Oncology (VHIO), Barcelona". undefined are not yet recruiting, 37 are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Vall d´Hebron Institute of Oncology (VHIO), Barcelona, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Vall d´Hebron Institute of Oncology (VHIO), Barcelona, 37 "Phase 1" clinical trials were conducted, 41 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Vall d´Hebron Institute of Oncology (VHIO), Barcelona has several departments that took part in Clinical trials: "Hospital Universitari Vall d'Hebron - Vall d'Hebron Institut d'Oncologia (VHIO)" - 2 trials, "Vall d'Hebron Institut d'Oncologia (VHIO)" - 2 trials